WO2007090134A3 - Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma - Google Patents
Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma Download PDFInfo
- Publication number
- WO2007090134A3 WO2007090134A3 PCT/US2007/061331 US2007061331W WO2007090134A3 WO 2007090134 A3 WO2007090134 A3 WO 2007090134A3 US 2007061331 W US2007061331 W US 2007061331W WO 2007090134 A3 WO2007090134 A3 WO 2007090134A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glaucoma
- antagonists
- prevention
- treatment
- vanilloid receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Abstract
Compositions and methods for treating glaucoma and for treating or preventing retina damage resulting from glaucoma with vanilloid receptor-1 antagonist compounds are disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76374006P | 2006-01-31 | 2006-01-31 | |
US60/763,740 | 2006-01-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007090134A2 WO2007090134A2 (en) | 2007-08-09 |
WO2007090134A3 true WO2007090134A3 (en) | 2007-11-08 |
Family
ID=38320607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/061331 WO2007090134A2 (en) | 2006-01-31 | 2007-01-31 | Use of vanilloid receptor-1 antagonists for the prevention and treatment of glaucoma |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR059244A1 (en) |
TW (1) | TW200738232A (en) |
UY (1) | UY30120A1 (en) |
WO (1) | WO2007090134A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2719515C (en) | 2008-04-18 | 2013-11-05 | Daewoong Pharmaceutical Co., Ltd. | A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof |
JP2010024219A (en) * | 2008-06-18 | 2010-02-04 | Santen Pharmaceut Co Ltd | Therapeutic agent for optic nerve disorder |
KR101293384B1 (en) | 2010-10-13 | 2013-08-05 | 주식회사 대웅제약 | Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof |
AU2020222348B2 (en) | 2019-02-15 | 2023-03-16 | Bausch + Lomb Ireland Limited | Methods for treating ocular surface pain |
JP6994061B2 (en) | 2019-02-15 | 2022-01-14 | ノバルティス アーゲー | Preparation of 4- (7-hydroxy-2-isopropyl-4-oxo-4H-quinazoline-3-yl) -benzonitrile |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005004866A1 (en) * | 2003-06-12 | 2005-01-20 | Euro-Celtique, S.A. | Therapeutic agents useful for treating pain |
-
2007
- 2007-01-26 TW TW096102985A patent/TW200738232A/en unknown
- 2007-01-30 UY UY30120A patent/UY30120A1/en not_active Application Discontinuation
- 2007-01-30 AR ARP070100388A patent/AR059244A1/en not_active Application Discontinuation
- 2007-01-31 WO PCT/US2007/061331 patent/WO2007090134A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005004866A1 (en) * | 2003-06-12 | 2005-01-20 | Euro-Celtique, S.A. | Therapeutic agents useful for treating pain |
Non-Patent Citations (17)
Title |
---|
APPENDINO GIOVANNI ET AL: "Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 312, no. 2, February 2005 (2005-02-01), pages 561 - 570, XP002445729, ISSN: 0022-3565 * |
DOHERTY ELIZABETH M ET AL: "Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides", JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, no. 1, 13 January 2005 (2005-01-13), pages 71 - 90, XP002445730, ISSN: 0022-2623 * |
JETTER MICHELE C ET AL: "N-Isoquinolin-5-yl-N'-aralkyl-urea and -amide antagonists of human vanilloid receptor 1", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 12, 21 June 2004 (2004-06-21), pages 3053 - 3056, XP002445727, ISSN: 0960-894X * |
LEE JEEWOO ET AL: "Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N'-(4-(methylsulfonylamino)benzyl)thiou rea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 9, 3 May 2004 (2004-05-03), pages 2291 - 2297, XP002445723, ISSN: 0960-894X * |
LEE JEEWOO ET AL: "N-(4-(Methylsulfonylamino)benzyl)thiourea analogues as vanilloid receptor antagonists: Analysis of structure-activity relationships for the 'C-Region'.", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 12, no. 2, 15 January 2004 (2004-01-15), pages 371 - 385, XP002445719, ISSN: 0968-0896 * |
MCDONNELL MARK E ET AL: "7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 2, 19 January 2004 (2004-01-19), pages 531 - 534, XP002445720, ISSN: 0960-894X * |
PARK HYEUNG-GEUN ET AL: "N-4-methansulfonamidobenzyl-n'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 7, 5 April 2004 (2004-04-05), pages 1693 - 1696, XP002445722, ISSN: 0960-894X * |
PARK HYEUNG-GEUN ET AL: "N-4-substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: Investigation on the role of methanesulfonamido group in antagonistic activity.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 3, 9 February 2004 (2004-02-09), pages 787 - 791, XP002445721, ISSN: 0960-894X * |
PARK HYEUNG-GEUN ET AL: "Synthesis of 2-substituted-pyrrolidinethiourea derivatives and their antagonist effect on vanilloid receptor.", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 2, 20 January 2003 (2003-01-20), pages 197 - 200, XP002445716, ISSN: 0960-894X * |
PARK HYEUNG-GEUN ET AL: "Synthesis of N,N',N''-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor.", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 4, 24 February 2003 (2003-02-24), pages 601 - 604, XP002445717, ISSN: 0960-894X * |
RAMI HARSHAD K ET AL: "Discovery of small molecule antagonists of TRPV1", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 14, 16 July 2004 (2004-07-16), pages 3631 - 3634, XP002445724, ISSN: 0960-894X * |
RYU CHONG HYUN ET AL: "Chain-branched 1,3-dibenzylthioureas as vanilloid receptor 1 antagonists.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 7, 5 April 2004 (2004-04-05), pages 1751 - 1755, XP002445726, ISSN: 0960-894X * |
SUN Q ET AL: "4-(2-pyridyl)pipereazine-1-carboxamides: potent Vanilloid Receptor 1 antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 13, 20 October 2003 (2003-10-20), pages 3611 - 3616, XP002307277, ISSN: 0960-894X * |
SWANSON DEVIN M ET AL: "Identification and biological evaluation of 4-(3-trifluoromethylpyrid in-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)a mide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist", JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, no. 6, March 2005 (2005-03-01), pages 1857 - 1872, XP002445733, ISSN: 0022-2623 * |
TAFESSE LAYKEA ET AL: "Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 22, 15 November 2004 (2004-11-15), pages 5513 - 5519, XP002445725, ISSN: 0960-894X * |
TÓTH ATTILA ET AL: "Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population.", MOLECULAR PHARMACOLOGY FEB 2004, vol. 65, no. 2, February 2004 (2004-02-01), pages 282 - 291, XP002445728, ISSN: 0026-895X * |
XI NING ET AL: "Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 15, no. 23, December 2005 (2005-12-01), pages 5211 - 5217, XP002445734, ISSN: 0960-894X * |
Also Published As
Publication number | Publication date |
---|---|
WO2007090134A2 (en) | 2007-08-09 |
AR059244A1 (en) | 2008-03-19 |
UY30120A1 (en) | 2007-05-31 |
TW200738232A (en) | 2007-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010030813A3 (en) | Methods for inhibiting ocular angiogenesis | |
IL186598A0 (en) | Composition and method for the treatment or prevention of glaucoma and ocular hypertension | |
WO2006015775A3 (en) | Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders | |
WO2005072308A3 (en) | Cgrp receptor antagonists | |
WO2007003411A3 (en) | Kinin antagonists for treating bladder dysfunction | |
WO2008029276A8 (en) | Compositions and methods for the treatment of ophthalmic disease | |
WO2006091459A3 (en) | Compositions and methods for treating vascular permeability | |
WO2007111864A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
WO2007120980A3 (en) | 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases | |
WO2007136577A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
WO2008079988A3 (en) | Quinazolines for pdk1 inhibition | |
WO2008076754A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
WO2011112766A3 (en) | Heterocyclic inhibitors of histamine receptors for the treatment of disease | |
WO2008024439A3 (en) | 4-aminoquinazoline derivatives and methods of use thereof | |
WO2008011392A8 (en) | Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation | |
WO2006044775A3 (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
WO2007100617A3 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
WO2009061807A3 (en) | Activin receptor-like kinase-i antagonist compositions and methods of use | |
SI2176252T1 (en) | 2, 3-dihydrobenzoš1, 4ćdioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases | |
WO2011112731A3 (en) | Heterocyclic inhibitors of histamine receptors for the treatment of disease | |
WO2007141284A3 (en) | Treatment of gastrointestinal disorders with cgrp antagonists | |
WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
WO2006034512A3 (en) | Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes | |
WO2007112121A3 (en) | Tetracycline compounds and methods of treatment | |
WO2006078554A3 (en) | Cgrp receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07710408 Country of ref document: EP Kind code of ref document: A2 |